{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T20:17:52Z","timestamp":1774124272970,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1378\/chest.124.6.2112","type":"journal-article","created":{"date-parts":[[2003,12,9]],"date-time":"2003-12-09T18:48:43Z","timestamp":1070995723000},"page":"2112-2118","source":"Crossref","is-referenced-by-count":30,"title":["Initial Experience on Rifampin and Pyrazinamide vs Isoniazid in the Treatment of Latent Tuberculosis Infection Among Patients With Silicosis in Hong Kong"],"prefix":"10.1016","volume":"124","author":[{"given":"Chi Chiu","family":"Leung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wing Sze","family":"Law","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwok Chiu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheuk Ming","family":"Tam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wing Wai","family":"Yew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi Kuen","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man Yee","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.124.6.2112_bib1","unstructured":"Annual report of the Tuberculosis and Chest Service. Hong Kong, China: Hong Kong Tuberculosis and Chest Service of the Department of Health, 2000; Appendix 1 of Part 1 and Part 2"},{"key":"10.1378\/chest.124.6.2112_bib2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1164\/ajrccm\/145.1.36","article-title":"Madras\/BMJ Research Council. A double-blind placebo-controlled clinical trial of three anti-tuberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong","volume":"145","author":"Hong Kong Chest Service\/Tuberculosis Research Centre","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.124.6.2112_bib3","first-page":"177","article-title":"Tuberculosis risk factors in a silicotic cohort in Hong Kong","volume":"5","author":"Chang","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1378\/chest.124.6.2112_bib4","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJM199709183371201","article-title":"A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus","volume":"337","author":"Whalen","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.124.6.2112_bib5","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(97)06532-X","article-title":"Randomised trial of isoniazid versus rifampin and pyrazinamide for prevention of tuberculosis in HIV-1 infection","volume":"351","author":"Halsey","year":"1998","journal-title":"Lancet"},{"key":"10.1378\/chest.124.6.2112_bib6","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1097\/00002030-199818000-00014","article-title":"Twice-weekly tuberculosis preventive therapy in HIV infection in Zambia","volume":"12","author":"Mwinga","year":"1998","journal-title":"AIDS"},{"key":"10.1378\/chest.124.6.2112_bib7","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.283.11.1445","article-title":"Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons","volume":"283","author":"Gordin","year":"2000","journal-title":"JAMA"},{"key":"10.1378\/chest.124.6.2112_bib8","first-page":"1","article-title":"Guidelines for the use of ILO international classification of radiographs of pneumoconioses: revised edition","volume":"22","author":"International Labour Office","year":"1980","journal-title":"Occup Safety Health Series"},{"key":"10.1378\/chest.124.6.2112_bib9","first-page":"1319","article-title":"Update: fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society\/CDC recommendations\u2013United States, 2001","volume":"164","author":"American Thoracic Society","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.124.6.2112_bib10","unstructured":"Annual report of Tuberculosis and Chest Service, Hong Kong, China: Hong Kong Tuberculosis and Chest Service of the Department of Health, 1970; Appendix 1"},{"key":"10.1378\/chest.124.6.2112_bib11","doi-asserted-by":"crossref","first-page":"640","DOI":"10.7326\/0003-4819-137-8-200210150-00007","article-title":"Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial","volume":"137","author":"Jasmer","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.124.6.2112_bib12","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1164\/rccm.200209-998OC","article-title":"Safety of 2 months of rifampin and pyrazinamide for treatment of latent tuberculosis","volume":"167","author":"Stout","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.124.6.2112_bib13","first-page":"998","article-title":"Update: fatal and severe liver injuries associated with rifampin and pyrazinamide treatment for latent tuberculosis infection","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1378\/chest.124.6.2112_bib14","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1378\/chest.119.3.833","article-title":"Acceptability of short-course rifampin and pyrazinamide treatment of latent tuberculosis infection among jail inmates","volume":"119","author":"Bock","year":"2001","journal-title":"Chest"},{"key":"10.1378\/chest.124.6.2112_bib15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/thx.51.2.132","article-title":"Risk factors for hepatotoxicity from antituberculous drugs: a case-control study","volume":"51","author":"Pande","year":"1996","journal-title":"Thorax"},{"key":"10.1378\/chest.124.6.2112_bib16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/hep.510310129","article-title":"Antituberculous drug-related liver dysfunction in chronic hepatitis B infection","volume":"31","author":"Wong","year":"2000","journal-title":"Hepatology"},{"key":"10.1378\/chest.124.6.2112_bib17","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1046\/j.1532-5415.2002.50308.x","article-title":"Tuberculosis in older people: a retrospective and comparative study from Hong Kong","volume":"50","author":"Leung","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"10.1378\/chest.124.6.2112_bib18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1440-1746.1997.tb00353.x","article-title":"A prospective clinical study of isoniazid-rifampin-pyrazinamide-induced liver injury in an area endemic for hepatitis B","volume":"12","author":"Hwang","year":"1997","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1378\/chest.124.6.2112_bib19","first-page":"348","article-title":"Pyrazinamide and isoniazid used in the treatment of pulmonary tuberculosis","volume":"81","author":"Matthews","year":"1960","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.124.6.2112_bib20","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1378\/chest.94.4.845","article-title":"The role of pyrazinamide in tuberculosis chemotherapy","volume":"94","author":"Steele","year":"1988","journal-title":"Chest"},{"key":"10.1378\/chest.124.6.2112_bib21","first-page":"325","article-title":"Short course chemotherapy for pulmonary tuberculosis","volume":"111","author":"Fox","year":"1975","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.124.6.2112_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0041-3879(86)90003-6","article-title":"Hepatic toxicity in South Indian patients during treatment of tuberculosis with short-course regimens containing isoniazid, rifampin and pyrazinamide","volume":"67","author":"Parthasarathy","year":"1986","journal-title":"Tubercle"},{"key":"10.1378\/chest.124.6.2112_bib23","first-page":"65","article-title":"The management of anti-tuberculosis drug-induced hepatotoxicity","volume":"5","author":"Tahaoglu","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1378\/chest.124.6.2112_bib24","first-page":"699","article-title":"Hepatotoxicity of tuberculosis chemotherapy under general programme conditions in Singapore","volume":"6","author":"Teleman","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1378\/chest.124.6.2112_bib25","first-page":"279","article-title":"Correlation between steady-state plasma concentration of antituberculous drugs and age, inclusion of rifampin in the treatment regimen, adverse drug reactions and other clinical parameters","volume":"26","author":"Woo","year":"1995","journal-title":"J Med"},{"key":"10.1378\/chest.124.6.2112_bib26","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0962-8479(96)90098-2","article-title":"Liver injury during antituberculous treatment: an 11-year study","volume":"77","author":"Dossing","year":"1996","journal-title":"Tuberc Lung Dis"},{"key":"10.1378\/chest.124.6.2112_bib27","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0140-6736(95)90980-X","article-title":"Emergence of fluoroquinolone-resistant tuberculosis in New York City","volume":"345","author":"Sullivan","year":"1995","journal-title":"Lancet"},{"key":"10.1378\/chest.124.6.2112_bib28","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJM199404283301718","article-title":"Limited tolerance of ofloxacin and pyrazinamide prophylaxis against tuberculosis [letter]","volume":"330","author":"Horn","year":"1994","journal-title":"N Engl J Med"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215316664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215316664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,16]],"date-time":"2019-02-16T05:22:39Z","timestamp":1550294559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215316664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S0012369215316664"],"URL":"https:\/\/doi.org\/10.1378\/chest.124.6.2112","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}